Swiss drugmaker Roche entered a licensing agreement ​worth up to $1.16 billion with ‌Rona Therapeutics for its investigational obesity drug candidate, the Chinese biotech ​firm said on Tuesday.

Log in or sign up to comment.

No comments yet.

← Back to stories